Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Neuropeptide Y (scrambled)

Copy Product Info
😃Good
Catalog No. TP2194

Neuropeptide Y (NPY) is a 36-amino acid neuropeptide that exerts its activity via G-protein-coupled receptors. NPY is widely distributed in the peripheral and central nervous systems. It modulates a variety of physiological processes, e.g. the central regulation of vasoconstriction, memory retention and food intake, and the regulation of circadian rhythm.

Neuropeptide Y (scrambled)

Neuropeptide Y (scrambled)

Copy Product Info
😃Good
Catalog No. TP2194
Neuropeptide Y (NPY) is a 36-amino acid neuropeptide that exerts its activity via G-protein-coupled receptors. NPY is widely distributed in the peripheral and central nervous systems. It modulates a variety of physiological processes, e.g. the central regulation of vasoconstriction, memory retention and food intake, and the regulation of circadian rhythm.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$632InquiryInquiry
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Resource Download

Product Introduction

Bioactivity
Description
Neuropeptide Y (NPY) is a 36-amino acid neuropeptide that exerts its activity via G-protein-coupled receptors. NPY is widely distributed in the peripheral and central nervous systems. It modulates a variety of physiological processes, e.g. the central regulation of vasoconstriction, memory retention and food intake, and the regulation of circadian rhythm.
In vitro
Scrambled NPY peptide treatment had no effect on VEGF expression in 4T1 cells. Previous treatment with scrambled NPY at concentrations ranging from 10?10 to 10?7 M made conditioned media from 4T1 cells show no difference in the number of complete endothelial networks or branch points versus control in endothelial tube formation assays [2][3].
In vivo
In trimethyltin-treated (TMT-treated) rats, treatment with scrambled NPY for 24 h made the expression of Bdnf, NpyR, neurogenic and antiapoptotic genes comparable to that of saline-injected animals (without significant differences). In TMT-treated rats, both saline and scNPY showed no significant modulation (p> 0.05) in the expression levels of Npy1R, Npy2R, and Npy5R [4][5].
Chemical Properties
Molecular Weight4253.7
FormulaC190H287N55O57
Relative Density.no data available
SequenceSer-Lys-Pro-Gln-Arg-Asp-Ala-Asn-Arg-Glu-Pro-Thr-Arg-Tyr-Ala-Ile-Tyr-Asp-Tyr-Ser-Asn-Pro-Asp-Ile-Glu-Leu-His-Tyr-Leu-Arg-Pro-Ala-Tyr-Ala-Leu-Gly-NH2
Sequence ShortSKPQRDANREPTRYAIYDYSNPDIELHYLRPAYALG
Storage & Solubility Information
Storagekeep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
H2O: 1 mg/mL (0.24 mM), Sonication is recommended.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Neuropeptide Y (scrambled) | purchase Neuropeptide Y (scrambled) | Neuropeptide Y (scrambled) cost | order Neuropeptide Y (scrambled) | Neuropeptide Y (scrambled) in vivo | Neuropeptide Y (scrambled) in vitro | Neuropeptide Y (scrambled) formula | Neuropeptide Y (scrambled) molecular weight